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Abstract
CitS of Klebsiella pneumoniae and GltS of Escherichia coli are Na+-dependent secondary transporters from different families that
are believed to share the same fold and quaternary structure. A 10 kDa protein tag (Biotin Acceptor Domain [BAD]) was fused
to the N-terminus of both proteins (CitS-BAD1 and GltS-BAD1, respectively) and inserted in the central cytoplasmic loop
that connects the two halves of the proteins (CitS-BAD260 and GltS-BAD206). Both CitS constructs and GltS-BAD206 were
produced and shown to be active transporters, but GltS-BAD1 could not be detected in the membrane. Distance relationships
in the complexes were studied by cross-linking studies. Both CitS constructs were shown to be in the dimeric state after
puriﬁcation in detergent by cross-linking with glutaraldehyde. The concentration of glutaraldehyde resulting in 50% cross-
linking was signiﬁcantly higher for CitS-BAD1 than for CitS and CitS-BAD260. Remarkably, GltS and GltS-BAD260 were
not cross-linked by glutaraldehyde because of the lack of productive reactive sites. Cross-linking of GltS was observed when the
N-terminal 46 residues of CitS with or without BAD at the N-terminus were added to the N-terminus of GltS. The stretch of
46 residues contains the ﬁrst transmembrane segment of CitS that is missing in the GltS structure. The data support an
orientation of the monomers in the dimer with the N-termini close to the dimer interface and the central cytoplasmic loops far
away at the ends of the long axis of the dimer structure in a view perpendicular to the membrane.
Keywords: Transport protein, dimer, cross-linking, glutaraldehyde
Abbreviations: TMS, transmembrane segment; BAD, biotin acceptor domain; NEM, N-ethylmaleimide; DDM,
b-dodecyl maltoside; RSO, right-side-out; PMS, phenazine methosulfate.
Introduction
CitS of Klebsiella pneumoniae and GltS of Escherichia
coli are secondary transporters catalyzing Na+ symport
that belong to different families. The Na+-citrate
transporter CitS belongs to the 2-hydroxycarboxylate
transporter (2HCT; TC 2.A.24 [Saier 2000]) family
(Sobczak and Lolkema 2005) while the Na+-gluta-
mate transporter GltS belongs to the Glutamate
Sodium Symporter (ESS; TC 2.A.27) family. Mem-
bers of the 2HCT and ESS families are found exclu-
sively in bacteria. No sequence homology can be
detected between members from the two families,
but both families are found in the same structural
class ST[3] of the MemGen classiﬁcation (Lolkema
and Slotboom 1998, 2003, 2008) implying that
the members are structurally homologous, i.e., they
share the same core structure. MemGen class ST[3]
contains 32 families of secondary transporters
and includes the Ion Transporter (IT) superfamily
(Prakash et al. 2003). A high resolution 3D structure
is not available for any member of class ST[3].
Insight into the structure and function of class
ST[3] proteins comes in addition to sequence
analysis mainly from studies of CitS and GltS. The
structural model of the transporters (Figure 1) shows
a core of two homologous domains consisting of
ﬁve transmembrane segments (TMS) each that are
connected by a large cytoplasmic loop region (Van
Geest and Lolkema 1999, 2000, Lolkema et al. 2005,
Dobrowolski et al. 2007). The CitS protein and all
members of the 2HCT family have an additional
TMS at the N-terminal end of the core structure,
placing the N-terminus in the cytoplasm. Members of
the ESS family including GltS do not have this addi-
tional segment and their structure corresponds to the
core structure that has the N-terminus in the peri-
plasm. Other families in class ST[3] are characterized
by additional TMSs at the C-terminal end. Because of
the odd number of helices in the two domains that
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form the core structure, they have opposite orienta-
tions in the membrane (‘inverted topology’), a struc-
tural motif that is frequently observed in membrane
proteins. In between the 4th and 5th TMS in each
domain, the connecting loop folds back in between
the TMSs to form a so-called ‘pore loop’ or ‘reentrant
loop’ (Sobczak and Lolkema 2004, Dobrowolski and
Lolkema 2009). The reentrant loop in the N-terminal
domain enters the membrane from the periplasmic
side, the one in the C-terminal domain from the
cytoplasm. Sequence motifs GGXG present in the
transporters of both the 2HCT and ESS families are at
the vertex of the reentrant loops and were demon-
strated to be crucial for the activity of the CitS and
GltS proteins (Dobrowolski and Lolkema 2009).
Recently, evidence was presented suggesting that in
the 3D structure, the pore-loops of the two domains
are in close vicinity and overlapping at the interface of
the two domains (Dobrowolski and Lolkema 2010).
The two domains would fold upon each other as the
two halves of a clam shell with the central cytoplasmic
loop forming the hinge at the closed side and the N-
and C-termini at the open side. It is believed that the
two pore loops form the translocation pore and that
translocation proceeds through an alternate access
mechanism (Sobczak and Lolkema 2003, 2004),
involving movement of the two domains relative to
one another (Dobrowolski and Lolkema 2010a).
In addition to a similar 3D structure, the CitS and
GltS proteins also share the same quaternary struc-
ture. Several techniques were used to demonstrate
that the proteins are dimeric in the detergent solubi-
lized state (Pos et al. 1994, Veenhoff et al. 2001,
Kästner et al. 2003, Mos´cicka et al. 2009). Single-
particle electron microscopy yielded projection maps
of the dimers showing in top view biscuit-shaped
particles of dimension 160  84 Å and 145  84 Å
for CitS and GltS, respectively. A side view projection
of CitS revealed asymmetry in the shape of the protein
relative to the plane of the membrane (Mos´cicka et al.
2009). In this study, proximity relations of the two
monomers in the dimeric structure was studied by
site-speciﬁc tagging of the monomers with the 10 kDa
Biotin Acceptor Domain (BAD) of the oxaloacetate
decarboxylase of Klebsiella pneumoniae (Bott 1997)
followed by cross-linking with glutaraldehyde. The
approach takes advantage of the observation that
the GltS monomers could not be cross-linked with
glutaraldehyde in the dimeric complex. The results
place the cytoplasmic loop that connects the two
domains of the monomers at the end of the long
axis of the dimer structure, while the N-terminus is
in the neighborhood of the dimer interface.
Methods
Materials
Ampicilin was obtained from Roche Diagnostic
GmbH, Mannheim, Germany, arabinose from
Sigma-Aldrich GmbH, Steinheim, Germany, and
[1,5-14C]-citrate and L-[14C]-glutamate from
Amersham Pharmacia, Roosendaal, The Netherlands.
Growth conditions and membrane preparation
CitS and GltS transporters were expressed in
Escherichia coli strain DH5a under control of the
arabinose promoter using pBAD24 (Invitrogen)
derived plasmids. Freshly transformed bacteria were
used to inoculate an overnight preculture. Twenty-
ﬁve ml of preculture was added to 1 l of Lysogeny
broth (LB)medium containing 50 mg/ml ampicilin in a
5-l ﬂask at 37C that was under continuous shaking at
200 rpm. At an OD660 of 0.6, 0.1% arabinose (Sigma-
Aldrich GmbH, Steinheim, Germany) was added to
induce expression of the transporters after which the
culture was allowed to grow for an additional hour.
Cells were harvested by spinning at 8000 rpm at 4C
for 10 min, washed with 50 ml 50 mM KPi, pH 7 at
4C and resuspended in the same buffer. Cells from a
1-l culture resuspended in 5 ml of buffer containing
1 mg/ml DNAse were passed three times through a
pressure-cell-disrupter at 13.5 MPa at 4C. Following
a low spin at 8,000 rpm for 10 min at 4C to remove
debris and unbroken cells, the supernatant was cen-
trifuged at 80,000 rpm for 25 min at 4C (high spin).
The membrane fraction was resuspended and washed
once with 50 mM KPi pH 7 buffer containing 1 M
NaCl. The membranes were resuspended in 1 ml











Figure 1. Structural model of class ST[3] transporters. Cylinders
represent transmembrane segments. The homologous N and C
domains were indicated in dashed boxes. VB and XA represent
reentrant loops. Arrows point at the insertion/fusion sites of the
BAD domain in the indicated hybrid proteins. Shown is the model
for CitS of K. pneumoniae. GltS of E. coli lacks the ﬁrst transmem-
brane segment. The N terminus of CitS is in the cytoplasm.
























































All genetic manipulations were done in E. coli DH5a
using standard techniques. Plasmids pBADCitS and
pSB260 were described before (Van Geest and
Lolkema 1996, Sobczak and Lolkema 2003). pBAD-
CitS encodes the CitS protein extended with a
N-terminal His6-tag and an enterokinase cleavage
site. pSB260 is a pBlueScript II (Stratagene) deriva-
tive containing the citS gene with the gene encoding
BAD inserted in a NcoI restriction site at a position
corresponding to amino acid residue 260 in the CitS
sequence. The BAD encoding sequence was excised
from pSB260 and ligated into the unique NcoI site of
pBADCitS situated in between the enterokinase site
and CitS encoding sequences yielding plasmid pCitS-
BAD1. Plasmid pCitS-BAD260 was obtained by
replacing a Bpu1102I-XbaI fragment of pBADCitS
with the corresponding fragment including the BAD
encoding sequence of pSB260.
Plasmids pBADGlts and pN356C encoding the
GltS protein and GltS N356C mutant, respectively,
both extended with a N-terminal His6-tag, were
described before (Dobrowolski et al. 2007, Dobro-
wolski and Lolkema 2009). Plasmid pGltS-BAD1 was
obtained by ligation of the BAD encoding fragment
with NcoI overhangs into the NcoI site of pN356C
situated in between the His-tag and GltS encoding
sequences. Plasmid pGltS-BAD206 was obtained in a
similar way after introduction of a unique NcoI cleav-
age site at the position of the 206th amino acid in
GltS. Plasmid pTMSI-GltS was obtain by introduc-
ing an additional NcoI site at the position of the 46th
amino acid in the citS gene, cutting theNcoI fragment
from the plasmid and ligating the fragment into the
NcoI site of pN356C. The second NcoI site was
mutated to a NdeI site to introduce a TEV cleavage
site in the encoded protein by ligating two hybridized
complementary synthetic primers encoding the TEV
site and with NdeI overhangs. Plasmid pBAD-TMSI-
GltS was obtained by insertion of the BAD encoding
sequence into the remaining NcoI site of pTMSI-
GltS. The GltS derivatives containing the TEV pro-
tease sites could not be cleaved with the TEV enzyme.
This feature was not further used in this study.
Plasmid pBAD was produced by introduction of a
NcoI site just in front of the stop codon in pGltS-
BAD1 followed by restriction with NcoI and relega-
tion. pBAD encodes the BAD protein extended with a
His-tag at the N-terminus.
Puriﬁcation of CitS and GltS derivatives
CitS and GltS derivatives were puriﬁed to homoge-
neity as described before (Mos´cicka et al. 2009).
Brieﬂy, transporter proteins were solubilized from
the membranes by partial extraction. Membranes
from a 1-l culture incubated for 1 h at 4C and under
continuous shaking in 50 mM KPi pH 7 buffer con-
taining 400 mM NaCl, 10% glycerol and 0.5%
b-dodecyl maltoside (DDM). Undissolved mem-
brane material which contained the transporter pro-
teins was recovered by spinning at 80,000 rpm for
25 min at 4C. The extraction procedure was
repeated with the same buffer containing 1% Triton
X-100 instead of DDM. The transporter proteins
were recovered from the supernatant after spinning.
The supernatant was passed through a 0.2 mm ﬁlter
and applied to a 1 ml bed volume Ni-NTA column
(HisTrap HP) in an ÄKTA FPLC system. Before, the
column was conditioned for 5 min at 1 ml/min ﬂow
rate of the carrier buffer (50 mM KPi pH 8, 600 mM
NaCl, 10% glycerol, 0.03% DDM, 20 mM imidaz-
ole). The loaded column was washed with 10 ml of
6% of the elution buffer (50 mM KPi pH 7, 600 mM
NaCl, 10% glycerol, 0.03% DDM, 500 mM imidaz-
ole). The proteins were eluted in a linear gradient of
6–80% of the elution buffer. The OD280 of the eluate
was measured continuously, after which the eluate
was collected in fractions of 0.5 ml.
Expression levels of CitS and GltS derivatives in
right-side-out (RSO) membrane vesicles used in the
transport assays were measured by a batch wise partial
puriﬁcation procedure (Dobrowolski and Lolkema
2009). RSO membranes were solubilized in 1 ml of
50 mM KPi pH 7 buffer containing 400 mM NaCl,
10% glycerol and 1% Triton X-100 for 1 h at 4C
while shaking. The solubilized material was recovered
by spinning the samples in an ultracentrifuge at
80000 rpm for 25 min at 4C. The supernatant
fractions were mixed with Ni-NTA beads (50 ml
bed volume) preconditioned in 50 mM KPi pH 8,
600 mM NaCl, 10% glycerol, 0.1% Triton X-100
20 mM imidazole and left shaking at 4C for 12 h.
The Ni-NTA resin was recovered by brief spinning at
4,000 rpm at room temperature using a table top
centrifuge and washed three times with the equilibra-
tion buffer and once with the same buffer containing
40 mM imidazole. Proteins were eluted with 30 ml of
elution buffer (50 mM KPi pH 7, 600 mM NaCl,
10% glycerol, 0.03% DDM, 250 mM imidazole) and
analyzed by SDS-PAGE.
Transport studies
Right-side-out (RSO) membranes were prepared
from a 1-l culture by the osmotic shock procedure
as described (Kaback 1974). RSO membranes were
resuspended in 50 mM KPi pH 7.0 and aliquoted in
150 ml portions that were stored at80C.Membrane























































protein concentration in the samples was determined
by the DC protein assay kit (BioRad Laboratories,
Hercules, CA, USA).
RSO membrane vesicles were diluted to 1 mg/ml in
50 mM KPi pH 6 containing 100 mM NaCl. When
indicated RSO membranes containing the N356C
mutant of GltS were treated with 1 mM N-
ethylmaleimide (NEM) for 10 min. The treatment
was stopped by adding an equimolar concentration of
dithiothreitol. Aliquots of 100 ml were incubated for
2 min at 30C with 10 mM K-ascorbate and 100 mM
phenazine methosulfate (PMS) under a ﬂow of water-
saturated air and continuous stirring with a magnetic
bar. At t = 0, [1,5-14C]-citrate or L-[14C]glutamate
was added to ﬁnal concentrations of 4.4 and 2.9 mM,
respectively. Uptake was stopped at 5, 10, 20, 40,
60 sec by the addition of 2 ml ice-cold 0.1 M LiCl
followed by immediate ﬁltering over cellulose nitrate
ﬁlter (0.45 mm pore size) and washing of the ﬁlter with
an additional 2 ml of the LiCl solution. Filters were
collected and their radioactivity was measured in a
liquid scintillation counter.
Cross-linking studies
For each experiment, a 50 mM glutaraldehyde solu-
tion in water was prepared freshly from a stock
solution (Grade I, 25% aqueous glutaraldehyde solu-
tion, Sigma-Aldrich GmbH, Steinheim, Germany)
stored at 20C. Unless otherwise indicated, protein
samples were treated at 2 mM glutaraldehyde con-
centration for 10 min at room temperature. The
reaction was stopped by making the solution
100 mM in Tris-HCl pH 7 and incubating the
sample for another 10 min at room temperature
after which the samples were analyzed by SDS-
PAGE (Laemmli 1970) using a 12% polyacrylamide
gel and staining with Coomassie Brilliant Blue. The
intensity of the protein bands was measured using a
Fuji Imager LAS-4000.
Results
Biotin Acceptor Domain (BAD) tagged CitS
The Biotin Acceptor Domain (BAD) domain of the
oxaloacetate decarboxylase of Klebsiella pneumoniae is
a ~10 kDa protein moiety. The gene coding for BAD
was fused at the 5¢ end and inserted into the middle of
the Na+-citrate transporter gene citS yielding plasmids
pCitS-BAD1 and pCitS-BAD260, respectively. The
plasmids code for hybrid proteins consisting of the
CitS protein with BAD fused at the N-terminus and
with BAD inserted in the central cytoplasmic loop at
position 260 in between the two putative domains of
CitS, respectively. All constructs contain a His6-tag at
the N-terminus (Figure 2A).
Membrane vesicles with a right-side-out (RSO)
orientation were prepared from E. coli DH5a cells






















































Figure 2. BAD-tagged CitS transporters. (A) Schematic represen-
tation of CitS-BAD hybrids. h, His6-tag; CitS
N, N terminal domain
of CitS; CitSC, C terminal domain of CitS. (B) Uptake of
14C-citrate by RSO membranes containing CitS (.), CitS-
BAD1 (~) and CitS-BAD260 (&). Membrane protein concentra-
tions were 1 mg/ml. Citrate uptake was expressed in nmol per mg of
membrane protein in the sample. (C) SDS-PAGE of partially
puriﬁed CitS moieties from the RSO membrane vesicles used in
the uptake experiments shown in panel B. Lane 1, CitS, lane 2,
CitS-BAD1, lane 3, CitS-BAD260, left lane, marker proteins.
Molecular masses were indicated in kDa. Arrows at the right
(from top to bottom) point at the BAD-tagged CitS moieties and
CitS, respectively. (D) SDS-PAGE analysis after cross-linking of
CitS moieties with glutaraldehyde. Samples of puriﬁed CitS, CitS-
BAD1 and CitS-BAD260 were treated with 2 mM glutaraldehyde
(GA) for 20 min in the presence and absence of 1% SDS as
indicated at the bottom. Left lane, marker proteins with the molec-
ular masses indicated in kDa. Arrows at the right (from top to
bottom) points at dimeric CitS-BAD hybrids, dimeric CitS, mono-
meric CitS-BAD hybrids, and monmeric CitS.























































proteins and were assayed for citrate uptake activity.
Membrane vesicles prepared from the host strain are
completely devoid of citrate uptake activity because of
the lack of expression of citrate transporters during
aerobic growth of E. coli (not shown; Lolkema et al.
1994). The initial rate of uptake of citrate driven by a
proton motive force imposed by the artiﬁcial electron
donor system K-ascorbate/PMS of the RSO mem-
branes containing the two hybrid proteins was roughly
half of the rate observed for those containing wild-
type CitS (Figure 2B). The level of expression was
determined by purifying the proteins from the mem-
branes by Ni-NTA afﬁnity chromatography using a
batch-wise protocol. SDS-PAGE analysis of the par-
tially puriﬁed proteins revealed the two hybrid pro-
teins with apparent molecular masses of 50 kDa
(Figure 2C, lanes 2 and 3) which is about 10 kDa
more than the untagged CitS protein as expected
(lane 1). The intensity of the bands of the two hybrid
proteins was similar, but both were clearly less intense
than observed for wild-type CitS. The lower expres-
sion level of the two hybrid proteins largely explains
the difference in citrate uptake activity of the different
RSO membrane preparations in Figure 2B. Intro-
duction of BAD at the N-terminus and at position
260 of the CitS protein does not seem to signiﬁcantly
affect the transport activity of the CitS moieties. The
result is in line with the positive phenotype of E. coli
cells expressing the hybrid proteins on Simmons
agar indicator plates (Van Geest and Lolkema
1996, 2000).
Cross-linking of CitS and tagged CitS moieties
The CitS protein was shown before to be a dimer in
the detergent solubilized state by cross-linking with
glutaraldehyde (Dobrowolski and Lolkema 2010a).
In agreement, treatment of puriﬁed CitS with 2 mM
glutaraldehyde for 10 min shifted the protein band
on SDS-PAGE up to a protein with an apparent
molecular mass of 100 kDa (Figure 2D). Pretreat-
ment of the sample with SDS prevented the up shift
demonstrating that cross-linking in the native state is
not the result of collisions between monomeric
particles. The two hybrid proteins were puriﬁed to
homogeneity. Similarly, as observed for the CitS
protein, treatment of the hybrid proteins with glu-
taraldehyde resulted in an upshift of the proteins on
SDS-PAGE that was not observed with the unfol-
ded proteins (Figure 2D). For all cases, treatment
with glutaraldehyde resulted in more diffuse protein
bands, most likely due to the heterogeneity caused by
random labeling of the protein and/or intramolecular
cross-linking. It follows that the introduction of BAD
at the N-terminus and at position 260 of the CitS
protein does not interfere with the dimeric state of
the CitS moieties.
Using the same conditions, cross-linking of CitS-
BAD1 appeared to be less efﬁcient than observed for
CitS and CitS-BAD260. While the monomeric pro-
tein band had essentially disappeared in the case of
the latter two, a signiﬁcant band was still visible in
case of the former (see Figure 2D). The observation
was further substantiated by titration of the cross-
linking reaction with increasing concentrations of
glutaraldehyde. Densitometric analysis of the mono-
meric and dimeric protein bands (Figure 3A) showed
that within the accuracy of the experiment, the behav-
ior was similar for CitS and CitS-BAD260 with a
concentration of 0.29 ± 0.05 mM glutaraldehyde
giving 50% cross-linking. In marked contrast, the
concentration of glutaraldehyde required for 50%
cross-linking of CitS-BAD1 was signiﬁcantly higher,
1.2 ± 0.1 mM (Figure 3B). It follows that the
presence of BAD at the N-terminus of CitS nega-
tively affects the cross-linking efﬁciency while BAD
inserted in the central loop has no signiﬁcant effect
on cross-linking.
Biotin Acceptor Domain (BAD) tagged GltS
Asimilar setofhybridproteinsasdescribedabove for the
Na+-citrate transporter CitS was constructed with the
Na+-glutamate transporter GltS (Figure 4A). The
hybrids were constructed using the N356C mutant of
GltS which was shown to be equally active in accumu-
lating glutamate in RSO membranes but completely
inactive after treatment with NEM (Dobrowolski and
Lolkema 2009). The N356C mutant allows for the
estimation of the background activity by endogenous
glutamate transporters encoded on the chromosome of
the host cells. GltS-BAD1 has BAD fused to the
N-terminus and GltS-BAD206 has BAD inserted in
the cytoplasmic loop of GltS at position 206 which
corresponds to position 260 in CitS. In addition, a
control plasmid was constructed coding for the BAD
domain with an N-terminal His6-tag.
Membrane vesicles with a right-side-out (RSO)
orientation were prepared from E. coli DH5a cells
expressing the GltS mutant N356C and the hybrid
proteins and were assayed for glutamate uptake activ-
ity. Mutant N356C and GltS-BAD206 showed sim-
ilar uptake activities (Figure 4B). Pretreatment of
the membranes with NEM reduced the uptake to
the activity of endogenous glutamate transporters
(Dobrowolski and Lolkema 2009). In contrast, mem-
branes containing GltS-BAD1 revealed no signiﬁcant
activity above the level that was observed after treat-
ment of the same membranes with NEM. SDS-
PAGE analysis of the partially puriﬁed proteins























































revealed that the lack of activity of GltS-BAD1 was
due to an expression/insertion problem. While
the N356C mutant and GltS-BAD206 showed up
as clear protein bands with apparent molecular
masses of 35 and 45 kDa, respectively, as expected
(Figure 4C, lanes 1 and 3) (Mos´cicka et al. 2009), no
band could be observed at the expected size for GltS-
BAD1 (lane 2). It follows that, similarly as observed
for CitS, insertion of BAD in the central cytoplasmic
loop of the GltS protein did not signiﬁcantly affect the
transport activity of the protein, but, in contrast to
CitS, BAD fused at the N-terminus of GltS in GltS-
BAD1 decreased the expression level of the hybrid
protein. It should be noted that the N-termini of GltS
and CitS are located at opposite sites of the mem-
brane, in the periplasm and cytoplasm, respectively,
and, consequently, the BAD moiety in GltS-BAD1
has to be translocated across the membrane during
biogenesis.
Cross-linking of GltS and tagged GltS moieties
The GltS protein was shown to be dimeric by binding
afﬁnity to Ni-NTA, BN-PAGE, and EM analysis
(Mos´cicka et al. 2009) but not by cross-linking
with glutaraldehyde. Contrary to expectations, treat-
ment of puriﬁed GltS protein with 2 mM of glutar-
aldehyde for 10 min did not result in the appearance
of dimeric protein on SDS-PAGE (Figure 4D, left
panel). Some reduction in the intensity of the mono-
meric protein band was observed which was due to a
small fraction of aggregated protein that following
treatment with the cross-linker did not enter the
gel. Pretreatment of the sample with 1% of SDS
before cross-linking resolved the aggregates. The
cross-linking reaction was repeated with glutaralde-
hyde concentrations in the range of 0.1–3 mM, but
under none of these conditions cross-linking was
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Figure 3. Titration of cross-linking of CitS and BAD-tagged CitS with glutaraldehyde. (A) SDS-PAGE analysis of puriﬁed CitS, CitS-
BAD1 andCitS-BAD260 treated with the indicated concentration of glutaraldehyde (GA) for 10min. m, monomeric protein bands; d, dimeric
protein bands. (B) Densitometric analysis of the protein bands corresponding to monomeric and dimeric CitS (.,*), CitS-BAD1 (~,D), CitS-
BAD260 (&,&). The data points were ﬁtted to a sigmoidal curve after which the ‘begin’ and ‘end’ points of the curve were set to 100%.

































































































































Figure 4. BAD-tagged GltS transporters. (A) Schematic representation of GltS-BAD hybrids. h, His6-tag. GltS
N, N terminal domain of GltS.
GltSC, C terminal domain of GltS. The star indicates the N356C mutation in GltS. (B) Uptake of 14C-glutamate by RSO membranes
containing GltS (.), GltS-BAD206 (~) and GltS-BAD1 (&,&) before (&) and after (&) treatment of the membranes with 1 mM NEM for
10 min.Membrane protein concentrations were 1 mg/ml. Glutamate uptake was expressed in nmol per mg of membrane protein in the sample.
(C) SDS-PAGE of partial puriﬁed GltS moieties from the RSO membrane vesicles used in the uptake experiment shown in panel B. Lane 1,
GltS, lane 2, GltS-BAD1, lane 3, GltS-BAD206, left lane, marker proteins. Molecular masses were indicated in kDa. Arrows at the right (from
top to bottom) point at the BAD-tagged GltS moieties and GltS, respectively. (D) SDS-PAGE analysis after treatment of puriﬁed GltS (left),
GltS-BAD206 (middle) and the BAD protein (right) with 2 mM glutaraldehyde (GA) for 20 min in the presence and absence of 1% SDS as
indicated at the bottom. Left lanes, marker proteins with the molecular masses indicated in kDa. Arrows point at the monomeric protein bands.























































considered to be due to the lack of suitable cross-
linking sites on the protein which might be provided
by the BAD moiety added to GltS in the hybrid GltS-
BAD206 protein. To exclude the possibility that BAD
would drive dimerization of the hybrid, the domain
was puriﬁed and treated with glutaraldehyde. Under
the conditions of the experiment, BAD was a mono-
meric protein (Figure 4D, right panel). Treatment of
puriﬁed GltS-BAD206 with glutaraldehyde under the
same conditions did not show any cross-linking to the
dimer. Like for untagged GltS, a slight reduction of
the intensity of the monomer was observed and
aggregated material appeared (Figure 4D, middle
panel). In all cases, the aggregates resolved in the
presence of 0.1% SDS. It follows that insertion of the
10 kDa BAD domain in the central loop connecting
the N and C domains of GltS does not promote
cross-linking of the GltS complex.
The citrate transporter CitS carries an extra TMS at
the N-terminus which is not present in the glutamate
transporter GltS. In construct TMSI-GltS, the ﬁrst
TMS of CitS including the adjacent loop regions were
fused to the N-terminus of the N356Cmutant of GltS
(Figure 5A). Construct BAD-TMSI-GltS has, in
addition, the BAD domain fused to the N-terminus
and corresponds to the GltS version of the CitS-
BAD1 construct. Transport assays in RSO mem-
branes containing the TMSI-GltS construct showed
a signiﬁcantly higher uptake activity than after treat-
ment of the same membranes with NEM (Figure 5B).
The activity was ~20% of membranes containing
wild-type GltS which was mainly due to a lower level
of expression (not shown). In contrast to wild-type
GltS, a signiﬁcant fraction of the protein could be
cross-linked to the dimeric form by treatment with
glutaraldehyde (Figure 5C). The BAD-TMSI-GltS
construct revealed ~50% of the activity of wild type
GltS in RSO membranes (Figure 5B) with a compa-
rable level of expression (not shown). Treatment of
the hybrid protein with glutaraldehyde resulted in the
appearance of a cross-linked product (Figure 5D).
Titration of the reaction with increasing concentra-
tion of glutaraldehyde indicated that the concentra-
tion required to give 50% cross-linking was between
1 and 1.5 mM which is in the same range as observed
for cross-linking of CitS-BAD1 (Figure 3). The cross-
linked product has an apparent molecular mass that is
more than twice the apparent mass of the monomeric
species. However, since in the titration no interme-
diate bands were observed it is concluded that the
cross-linked product is dimeric. The slow mobility
must be a consequence of aberrant behavior of the
cross-linked dimer on SDS-PAGE. It follows that the
addition of the ﬁrst TMS of CitS with or without a
fused BAD moiety at the N-terminus of GltS allows
for the cross-linking of the GltS monomers in the
dimeric complex.
Discussion
The projection structure of the secondary transporters
CitS and GltS obtained by electron microscopy and
single particle averaging reported before gave several
new insights into the architecture of these relatively
small proteins (Mos´cicka et al. 2009). EM analysis of
puriﬁed CitS ofK. pneumoniae revealed two dominant
classes of 2D projection maps which were interpreted
as representing top and side views of the protein. The
top view showed a biscuit-shaped particle with a long
axis of about twice the length of the short axis
(Figure 6, top). In side view, CitS was kidney-shaped.
The shapes and sizes were consistent with a homo-
dimeric particle with an indentation at one side of the
membrane at the interface of the subunits that would
be formed by the short axis. The EM images of the
GltS protein of E. coli revealed the same overall shape
as observed for CitS but no clear discrimination
between top and side views was obtained. The aim
of the present study was to determine the relative
orientation of the monomers in the dimeric structure
by determining the position of the N-termini and the
central loops that connect the two putative domains in
the monomers. Distance relationships were inferred
by tagging the N-terminus and central loop with the
biotin acceptor domain (BAD) of the oxaloacetate
decarboxylase of K. pneumoniae and determining
their effect on cross-linking of the monomers in
the dimers by glutaraldehyde. Hybrids CitS-BAD1
(N-terminus), CitS-BAD260 (central loop) and GltS-
BAD206 (central loop) were active in Na+-dependent
transport (Figures 2 and 4) indicating that the trans-
porter parts of the proteins had retained their native
structure. The data support a relative orientation of
the monomers with the N-termini close to the dimer
interface and the central loops distant at the ends of
the long axis (Figure 6, bottom).
Support for the relative positions of the central loop
and N-terminus in the dimeric complex was obtained
from the cross-linking studies of CitS and GltS in
several ways. Monomeric glutaraldehyde is a bivalent
unspeciﬁc cross-linker that in proteins preferentially
reacts with the e-NH2 group of lysine residues, but,
for instance, also with the N atom of peptide bonds
(Wine et al. 2007). The CitS dimer solubilized
in detergent solution was readily cross-linked by
glutaraldehyde (Dobrowolski and Lolkema 2010a),
but, surprisingly, GltS was not while its dimeric
state was demonstrated using other techniques
(Mos´cicka et al. 2009); this study). The different
cross-linking behavior of GltS and CitS may reﬂect























































the different amino acid sequences of the two pro-
teins, but also be related to the extra TMS and
adjacent cytoplasmic N-terminus present at the
N-terminal side of the core structure of CitS that is
absent in GltS (see Figure 1). Titration of the cross-
linking of CitS by increasing concentrations of
glutaraldehyde suggested the latter view. The con-
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Figure 5. Fusions of TMSI of CitS to the GltS transporter. (A) Schematic representation of the TMSI-GltS and BAD-TMSI-GltS hybrids. h,
His6-tag; BAD, BAD domain; H0, N-terminal plus TMSI of CitS; t, TEV protease cleavage site. The star indicates the N356C mutation in
GltS. (B) Uptake of 14C-glutamate by RSO membranes containing TMSI-GltS (.,*) and BAD-TMSI-GltS (&,&) before (.,&;) and after
(*,&) treatment of the membranes with 1 mM NEM for 10 min. Membrane protein concentrations were 1 mg/ml. Glutamate uptake was
expressed in nmol per mg of membrane protein in the sample. (C) SDS-PAGE analysis after treatment of partially puriﬁed TMSI-GltS with
2 mM glutaraldehyde (GA) for 20 min in the presence and absence of 1% SDS as indicated at the bottom. Right lane, marker proteins with the
molecular masses indicated in kDa. (D) SDS-PAGE analysis of partially puriﬁed BAD-TMSI-GltS treated with the indicated concentrations of
glutaraldehyde (GA) for 10min in the presence and absence of 1% SDS as indicated at the bottom. Left lane, marker proteins. Arrows from top
to bottom point at the dimeric and monomeric protein bands, respectively.























































cross-linking was raised by a factor of four when BAD
was fused to the N-terminus of CitS (Figure 3).
Clearly, the presence of the BAD domain hinders
the cross-linking, most likely by covering up the sites
in CitS that result in cross-linking in the absence of
BAD. The cross-linking sites of the untagged CitS
would have to be close to BAD, i.e., close to the
N-terminus. The cross-linking of GltS when BAD
plus the ﬁrst TMS of CitS was fused at its N-termi-
nus, a chimera that was active in glutamate transport,
is in agreement with this view (Figure 5C). The
similar concentration of glutaraldehyde required to
obtain 50% cross-linking suggests a similar relative
position of the two BAD moieties as in the CitS-
BAD1 dimer (Figure 5D). Further evidence for close
proximity of the N-termini in the dimer was obtained
by the cross-linking of the GltS dimer when
TMS1 of CitS was fused at the N-terminus which
places the N-terminus of the construct in the cyto-
plasm (Figure 4C). The latter construct expressed
poorly but signiﬁcant activity of the TMSI-GltS
hybrid could be demonstrated. The complementary
experiment in which TMS1 plus the N-terminal resi-
dues of CitS were deleted failed because no expres-
sion of the deletion mutant was obtained (not shown).
Nevertheless, together these experiments suggest that
the N-termini of CitS and TMSI-GltS are close to the
dimeric interface allowing cross-linking of the mono-
mers by glutaraldehyde. Equally important was the
lack of effect on cross-linking when BAD was inserted
in the central cytoplasmic loop. No signiﬁcant differ-
ence was observed between the concentrations of
glutaraldehyde to obtain 50% cross-linking for CitS
and CitS-BAD260, suggesting no contribution of
BAD to the cross-linking (Figure 3). Also no cross-
linking of GltS was observed when BAD was inserted
in the central loop yielding GltS-BAD206. Appar-
ently, the BAD moieties in the central loop are to far
away to result in cross-linking.
The structural model for the monomeric subunits
of CitS and GltS consists of two homologous domains
with the substrate and co-ion translocation sites at the
interface of the two domains (Sobczak and Lolkema
2005). Strong support for the model was recently
obtained by demonstrating cross-linking between
the pore-loops situated between the 4th and 5th
TMS in each domain (Dobrowolski and Lolkema
2010a). In a simple three-dimensional model, the
two domains would fold upon each other like a
clam shell with the central loop that connects the
two domains forming the hinge at the ‘closed’ side
of the monomer and the N- and C-terminal ends at
the opposite ‘open’ side. In the dimer structure, the
monomers could be oriented ‘closed-to-closed’ or
‘open’ to ‘open’. The present results favor the latter
orientation with the ‘closed’ sides of the monomers in
the EM projection structure positioned at the end of
the long axis to far away to contribute to cross-
linking and the ‘open’ sides in close vicinity at the
dimer interface (see the model in Figure 6, bottom).
Recently, we constructed an artiﬁcial GltS trans-
porter (GltSswap) in which the two domains in the
monomer were swapped by disconnecting the central
loop and reconnecting the domains by a linker
between TMS1 and TMS10 (Dobrowolski and
Lolkema 2010b). The new ‘central loop’ (i.e., the
linker) resides in the periplasm rather than the cyto-
plasm. GltSswap with a 19 residue long linker was
equally active as wild type GltS, but, in the context
of the present study, even more surprisingly, the
protein was readily cross-linked by glutaraldehyde
(Dobrowolski and Lolkema 2010) while wild type
GltS is not. This strongly suggests that cross-linking
proceeds via the linker sequence in agreement with
the above conclusion that the N- and C-termini would
be close to the dimer interface. Most likely, peptide
bond N atoms provided the sites for cross-linking
since the linker did not contain lysine residues.
In the structural model, the periplasmic linker of
GltSswap and the endogenous central loop of wild












Figure 6. Relative orientation of the subunits in dimeric CitS and
GltS. Schematic top view structures of dimeric wild type CitS (top),
CitS-BAD206 (bottom left) and CitS-BAD1 (bottom right). Top
view was deﬁned as perpendicular to the membrane. The ‘closed’
and ‘open’ sides of the clam shell model of one subunit were
indicated. The connection at the ‘closed’ side is formed by the
central cytoplasmic loop. The N- and C-termini are positioned at
the ‘open’ side. Dimensions are based upon EM projection struc-
tures. Vertical and horizontal dashed lines indicate subunit and
domain interfaces, respectively. Circles in grey represent the BAD
domains.























































a top view projection structure but at different sides of
the membrane. The marked difference in contribu-
tion to cross-linking may reﬂect: (i) The structural
asymmetry in the dimer relative to the plane of the
membrane (side view; Mos´cicka et al. 2009), or (ii) a
deﬁned structure of the wild type central loop keeping
the loop in a ﬁxed position and hiding potential
reactive sites.
Conclusion
The two domains of monomeric CitS and GltS fold
upon each other like a clam shell with the connecting
cytoplasmic loop forming the hinge region at the
‘closed’ side. The CitS monomers in the dimer
were readily cross-linked by glutaraldehyde, in con-
trast to GltS that was not cross-linked at all. Tagging
the cytoplasmic loop with BAD had no effect on cross-
linking efﬁciency, suggesting that the cytoplasmic
loops (the ‘hinges’) are located at opposite sides of
the dimer. Tagging the N-terminus of CitS with BAD
or GltS with TMS1 of CitS (with or without BAD)
affected cross-linking of both transporters; CitS by
covering up suitable sites, thus decreasing cross-
linking efﬁciency and GltS by supplying suitable sites,
thus making cross-linking possible. This suggests that
theN-termini are located in close vicinity and that they
are at the ‘open’ sides of the monomers that form the
dimer interface. Together, the distances of the two
cytoplasmic loops and the two N-termini indicate that
the relative orientation of the monomers in the dimer
is ‘open-to-open’.
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